Skip to main content

Metrifonat

  • Chapter
  • 88 Accesses

Zusammenfassung

Chemische Bezeichnung: 0,0-dimethyl-(1hydroxy-2,2,2-trichloroethyl)-phosphonat.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abdi YA, Villén T (1991) Pharmacokinetics of metrifonate and its rearrangement product dichlorvos in whole blood. Pharmacol Toxicol 68: 137–139

    Article  PubMed  CAS  Google Scholar 

  • Averbook BJ, Anderson RJ (1983) Electrophysiological changes associated with chronic administration of organophosphates. Arch Toxicol 52: 167–172

    Article  PubMed  CAS  Google Scholar 

  • Bassant MH, Jazat-Poindessous F, Lamour Y (1996) Effects of metrifonate, a Cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats. J Cereb Blood Flow Metab 16: 1014–1025

    Article  PubMed  CAS  Google Scholar 

  • Becker RE, Colliver J, Elble R, Feldman E, Giacobini E, Kumar V, Markwell S, Moriearty P, Parks R, Shillcutt SD, Unni L, Vicari S, Womack C, Zec RF (1990) Effects of metrifonate, a long-acting Cholinesterase inhibitor, in Alzheimer disease: report of an open trial. Drug Dev Res 19: 425–434

    Article  Google Scholar 

  • Becker RE, Moriearty P, Surbeck R, Unni L, Varney A, Vicary SA (1994) Second and third generation Cholinesterase inhibitors: clinical aspects. In: Giacobini E, Becker R (eds) Alzheimer disease: therapeutic strategies. Birkhäuser, Boston, pp 172–178

    Google Scholar 

  • Becker RE, Colliver JA, Markwell SJ, Moriearty PL, Unni LK, Vicari S (1996) Double-blind placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease. Alzheimer Dis Assoc Disord 10: 124–131

    Article  PubMed  CAS  Google Scholar 

  • Bieber F, Creed Pettigrew L, Mas J, Schmitt F, Wermeling D (1995) Results of a phase IIa clinical trial with metrifonate. Psychopharmacol Bull 31: 554

    Google Scholar 

  • Blair D, Hoadley EC, Hutson DH (1975) The distribution of dichlorvos in the tissues of mammals after its inhalation or intravenous administration. Toxicol Appl Pharmacol 31: 243–253

    Article  PubMed  CAS  Google Scholar 

  • Blair D, Dix KM, Hunt PF, Thorpe E, Stevenson DE, Walker AIT (1976) Dichlorvos — a 2-year inhalation carcinogenesis study in rats. Arch Toxicol 35: 281–294

    Article  PubMed  CAS  Google Scholar 

  • Blokland A, Hinz V, Schmidt BH (1995) Effects of metrifonate and tacrine in the spatial morris task and modified irwin test: evaluation of the efficacy/safety profile in rats. Drug Dev Res 36: 166–177

    Article  CAS  Google Scholar 

  • Bolle WR (1956) Neguvon®: ein äuβerlich und innerlich anwendbares Insektizid, Larvizid und Ascarizid. Veterinärmedizinische Nachrichten 3: 155–172

    Google Scholar 

  • Cummings J, Bieber F, Mas J, Orazem J, Gulanski B (1997) Metrifonate in Alzheimer’s disease. Results of a dose-finding study. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM (eds) Alzheimer’s disease: biology, diagnosis and therapeutics. John Wiley and Sons, Chichester, pp 665–669

    Google Scholar 

  • Dubois KP, Cotter GJ (1955) Studies on the toxicity and mechanism of action of dipterex. Arch Industr Health 11: 53–60

    CAS  Google Scholar 

  • Edwards G, Breckenridge AM (1988) Clinical pharmakokinetics of antihelmintic drugs. Clin Pharmacokinet 15: 67–93

    PubMed  CAS  Google Scholar 

  • Hallak M, Giacobini E (1989) Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain. Neuropharmacology 28: 199–206

    Article  PubMed  CAS  Google Scholar 

  • Hinz VC, Grewig S, Schmidt BH (1996a) Metrifonate and dichlorvos: effects of a single oral administration on Cholinesterase activity in rat brain and blood. Neurochem Res 21: 339–345

    Article  PubMed  CAS  Google Scholar 

  • Hinz VC, Grewig S, Schmidt BH (1996b) Metrifonate induces Cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochem Res 21: 331–337

    Article  PubMed  CAS  Google Scholar 

  • Hofer W (1981) Chemistry of metrifonate and dichlorvos. Acta Pharmacol Toxicol 49: 7–14

    Article  CAS  Google Scholar 

  • Holmstedt B, Nordgren I, Sandoz M, Sundwall A (1978) Metrifonate: summary of toxicological and pharmacological information available. Arch Toxicol 41: 3–29

    Article  PubMed  CAS  Google Scholar 

  • Itoh A, Nitta A, Hirose M, Hasegawa T, Nabeshima T (1997a) Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal fore-brain-lesioned rats. Behav Brain Res 83: 165–167

    Article  PubMed  CAS  Google Scholar 

  • Itoh A, Nitta A, Katono Y, Usui M, Naruhashi K, Iida R, Hasegawa T, Nabeshima T (1997b) Effects of metrifonate on memory impairment and cholinergic dysfunction in rats. Eur J Pharmacol 322: 11–19

    Article  PubMed  CAS  Google Scholar 

  • Jones KH, Sanderson DM, Noakes DN (1968) Acute toxicity data for pesticides. World Rev Pest Control 7: 135–143

    CAS  Google Scholar 

  • Kronforst-Collins MA, Moriearty PL, Ralph M, Becker RE, Schmidt B, Thompson LT, Disterhoft JF (1997) Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits. Pharmacol Biochem Behav 56: 103–110

    Article  PubMed  CAS  Google Scholar 

  • Main AR (1979) Mode of action of anticholinesterases. Pharmacol Ther 6: 579–628

    Article  CAS  Google Scholar 

  • Metcalf RE, Fukuto RB, March RB (1959) Toxic action of dipterex® and DDVP in the house fly. J Econ Entomol 52: 44–49

    CAS  Google Scholar 

  • Mori F, Cuadra G, Giacobini E (1995) Metrifonate effects on acetylcholine and biogenic amines in rat cortex. Neurochem Res 20: 1081–1088

    Article  PubMed  CAS  Google Scholar 

  • Moriearty PL, Womack CL, Dick BW, Colliver JA, Robbs RS (1991) Stability of peripheral hematological parameters after chronic acetylcholinesterase inhibition in man. Am J Hematol 37: 280–282

    Article  PubMed  CAS  Google Scholar 

  • Morris J, Cyrus P, Orazem J, Mas J, Bieber F, Gulanski B (1997) Metrifonate: potential therapy for Alzheimer’s disease. News session — Poster, 49. Annu Meet Am Acad Neurol, Boston, Apr 1997

    Google Scholar 

  • Nordgren I, Holmstedt B, Bengtsson E, Finkel Y (1981) Plasma levels of metrifonate and dichlorvos during treatment of schistosomiasis with bilarcil. Acta Pharmacol Toxicol 48: 79–86

    Google Scholar 

  • Nordgren I, Karlen B, Kimland M (1992) Metrifonate and tacrine: a comperative study on their effect on acetylcholin dynamics in mouse brain. Pharmacol Toxicol 71: 236–240

    Article  PubMed  CAS  Google Scholar 

  • Ogane N, Giacobini E, Messamore E (1992) Preferential inhibition of acetylcholinesterase molecular forms in rat brain. Neurochem Res 17: 489–495

    Article  PubMed  CAS  Google Scholar 

  • Pacheco G, Palacios-Esquivel R, Moss DE (1995) Cholinesterase inhibitors proposed for treating dementia in Alzheimer’s disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase. J Pharmacol Exp Ther 274: 767–770

    PubMed  CAS  Google Scholar 

  • Reiner E, Plestina R (1979) Regeneration of Cholinesterase activities in humane and rats after inhibition of 0,0-dimethy1-2,2-dichlorovinyl phosphate. Toxicol Appl Pharmacol 49: 451–454

    Article  PubMed  CAS  Google Scholar 

  • Reynolds JEF (1989) Martindale: the extra pharmacopoeia, 29th ed. The Pharmaceutical Press, London

    Google Scholar 

  • Riekkinen P jr, Schmidt B, Stefanski R, Kuitunen J, Riekkinen M (1996) Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats. Eur J Pharmacol 309: 121–130

    Article  PubMed  CAS  Google Scholar 

  • Riekkinen M, Schmidt B, Riekkinen P jr (1997) Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate. Eur J Pharmacol 338: 105–110

    Article  PubMed  CAS  Google Scholar 

  • Scali C, Giovannini MG, Bartolini L, Prosperi C, Hinz V, Schmidt BP, Pepeu G (1997) Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur J Pharmacol 325: 173–180

    Article  PubMed  CAS  Google Scholar 

  • Schmidt BH, Hinz VC, Blokland A, Van Der Staay F-J, Fanelli RJ (1996) Preclinical pharmacology of metrifonate: a promise for Alzheimer therapy. In: Becker R, Giacobini E (eds) Alzheimer disease: from molecular biology to therapy. Birkhäuser, Boston, pp 217–221

    Google Scholar 

  • Schmidt BH, Hinz VC, Van Der Staay F-J (1997) Cognition enhancement by metrifonate: evidence from animal studies. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM (eds) Alzheimer’s disease: biology, diagnosis and therapeutics. John Wiley and Sons, Chichester, pp 781–786

    Google Scholar 

  • Shekhar KC (1991) Schistosomiasis drug therapy and treatment considerations. Drugs 42: 379–405

    Article  PubMed  CAS  Google Scholar 

  • Sherman M, Ross E (1961) Acute and subchronic toxicity of insecticides to chicks. Toxicol Appl Pharmacol 3: 521–533

    Article  CAS  Google Scholar 

  • Škrinjaric-Špoljar M, Simeon V, Reiner E (1973) Spontaneous reactivation and aging of di-methylphosphorylated acetylcholinesterase and cholinesterases. Biochim Biophys Acta 315: 363–369

    Article  Google Scholar 

  • Unni LK, Womack C, Hannant ME, Becker RE (1994) Pharmacokinetics and pharmacodynamics of metrifonate in humane. Meth Find Exp Clin Pharmacol 16: 285–289

    CAS  Google Scholar 

  • Van Der Staay FJ, Hinz VC, Schmidt BH (1996a) Effects of metrifonate, its transformation product dichlorvos, and other organophosphorous and reference Cholinesterase inhibitors on Morris water escape behavior in young-adult rats. J Pharmacol Exp Ther 278: 697–708

    PubMed  Google Scholar 

  • Van Der Staay FJ, Hinz VC, Schmidt BH (1996b) Effects of metrifonate on escape and avoidance learning in young and aged rats. Behav Pharmacol 7: 56–64

    Google Scholar 

  • Villén T, Abdi YA, Erricsson Ö, Gustafsson LL, Sjöquist F (1990) Determination of metrifonate and dichlorvos in whole blood using gas chromatography and gas chromatography-mass spectrometry. J Chromatogr 529: 309–317

    Article  PubMed  Google Scholar 

  • Witter RF, Gaines TB (1963) Relationship between depression of brain or plasma Cholinesterase and paralysis in chicken caused by certain organic phosphorous compounds. Biochem Pharmacol 12: 1377–1386

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Retz, W., Rösler, M. (1999). Metrifonat. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6400-6_68

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6400-6_68

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7315-2

  • Online ISBN: 978-3-7091-6400-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics